Literature DB >> 21131108

A retrospective study about the influence of early nutritional support on mortality and nosocomial infection in the critical care setting.

C Serón-Arbeloa1, J Puzo-Foncillas, T Garcés-Gimenez, J Escós-Orta, L Labarta-Monzón, A Lander-Azcona.   

Abstract

BACKGROUND & AIMS: To determine whether early nutritional support reduces mortality and the incidence of nosocomial infection, in critically ill patients in the current practice.
METHODS: A retrospective observational study was conducted in all critically ill patients who had been prescribed nutritional support, throughout one year, in an Intensive Care Unit. The time to start and the route of delivery of nutritional support were determined by the attending clinician's assessment of gastrointestinal function and hemodynamic stability. Age, gender, severity of illness, start time and route of nutritional support, prescribed and delivered daily caloric intake for the first 7 days, whether they were a medical or surgical patient, length of stay in ICU, incidence rate of nosocomial infections and ICU mortality were recorded. Patients were classified according to whether or not they received nutritional support within 48 h of their admission to ICU and Binary Logistic Regression was performed to assess the effect of early nutritional support on ICU mortality and ICU nosocomial infections after controlling for confounders.
RESULTS: Ninety-two consecutive patients were included in the study. Start time of nutritional support showed a mean of 3.1 ± 1.9 days. Patients in the early nutritional support group had a lower ICU mortality in an unadjusted analysis (20% vs. 40.4%, p = 0.033). Early nutritional support was found to be an independent predictor of mortality in the regression analysis model (OR 0,28; 95% confidence interval, 0.09 to 0,84; p = 0.023). Our study did not demonstrate any association between early nutritional support and the incidence of nosocomial infection (OR 0.77; 95%. confidence interval, 0.26 to 2,24; p = 0.63), which was related to the route of nutritional support and the caloric intake. The delayed nutritional support group showed a longer length of stay and nosocomial infections than the early group, although these differences were not statistically significant.
CONCLUSIONS: Our study shows that early nutrition support reduces ICU mortality in critically ill patients, although it does not demonstrate any influence over nosocomial infection in the current practice in intensive care.
Copyright © 2010 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21131108     DOI: 10.1016/j.clnu.2010.11.004

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  5 in total

1.  Predictors of Clostridium difficile infection severity in patients hospitalised in medical intensive care.

Authors:  Nagham Khanafer; Abdoulaye Touré; Cécile Chambrier; Martin Cour; Marie-Elisabeth Reverdy; Laurent Argaud; Philippe Vanhems
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

2.  Effects of probiotics combined with early enteral nutrition on endothelin-1 and C-reactive protein levels and prognosis in patients with severe traumatic brain injury.

Authors:  Guohua Wan; Linlin Wang; Guanhong Zhang; Jian Zhang; Yanli Lu; Jun Li; Xinhao Yi
Journal:  J Int Med Res       Date:  2019-12-05       Impact factor: 1.671

3.  Enteral nutrition in critical care.

Authors:  Carlos Seron-Arbeloa; Monica Zamora-Elson; Lorenzo Labarta-Monzon; Tomas Mallor-Bonet
Journal:  J Clin Med Res       Date:  2013-01-11

4.  Influence of supplemental parenteral nutrition approach on nosocomial infection in pediatric intensive care unit of Emergency Department: a retrospective study.

Authors:  Dan Wang; Xiaoquan Lai; Chenxi Liu; Yuqi Xiong; Xinping Zhang
Journal:  Nutr J       Date:  2015-10-06       Impact factor: 3.271

5.  Effect of early enteral nutrition on patients with digestive tract surgery: A meta-analysis of randomized controlled trials.

Authors:  Xiao-Liang Shu; Kai Kang; Li-Juan Gu; Yong-Sheng Zhang
Journal:  Exp Ther Med       Date:  2016-08-01       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.